New Advances in Survival Studies Design
Register Now for this Free WebEx® Webinar

Designing better clinical trials for oncology, cardiovascular and infectious diseases using the new EastSurv® option for East 5®

Join Cytel Senior Biostatistician and East® Product Manager, Yannis Jemiai, in an examination of the new capabilities of the just released EastSurv option for East® 5. Live Q&A session with webinar attendees to follow.

Same 45 minute presentation - choose either date/time:
- Wednesday, October 10, 2007 - 10:00 AM Eastern US
- Tuesday, October 16, 2007 - 2:00 PM Eastern US

Download Presentation Slides or View WebEx Replay
Slides "New Advances in Survival Studies Design" .pdf

Launch WebEx Replay of the Oct10 Webinar

Webinar attendees will learn:
How to properly power a time-to-event survival trial by
 - specifying accrual duration and rate (sample size) & obtain study duration
 - specifying accrual and study duration and obtain sample size
 - analyzing the relationship between power, number of events, sample size, accrual duration, and study duration

How to incorporate common trial complications such as
 - variable accrual, variable hazard rates, variable drop-outs
 - fixed follow-up
 - departures from the proportional hazards assumption

Interim analyses planning best practices

Register Now - It's Easy
Cytel Webinars are FREE to you and your colleagues and there's no obligation.
To register, just choose the date and time link at the top of this page.

About Your Presenter - Yannis Jemiai, Ph.D.
As Senior Biostatistician and Product Manager for Cytel's East®, Yannis Jemiai has trained hundreds of statisticians and clinical trial professionals for Cytel. He’s also consulted for numerous major biopharmaceutical companies in adaptive and survival trial design, simulation, and analysis.

Dr. Jemiai has published in leading peer-reviewed journals on missing data and causal inference and has been an invited speaker at adaptive clinical trial and statistical meetings. Yannis earned his Ph.D. from Harvard University, an M.P.H. from Columbia University, and a B.A. in Molecular and Cellular Biology from Harvard University.

About EastSurv
Cytel’s EastSurv® option for East® enables superior survival study designs using methods far beyond simplified assumptions. EastSurv® helps trials designers make the toughest survival study design decisions with confidence by accounting for:

• variable subject drop-outs
• non-uniform accrual
• non-constant hazard rates
• variable and fixed subject follow-up
• lagged treatment effects and other non-proportional hazards scenarios